Two of America’s most highly respected mesothelioma professionals have been named to new positions at the prestigious International Mesothelioma Interest Group (iMig). Joseph Friedberg, MD, FACS, and Melissa Culligan, RN, BSN, MSc, PhD candidate will bring the expertise that they deploy at Temple Health, the Lewis Katz School of Medicine at Temple University, and Fox
Dr. Bruce E. Johnson is a world-renowned lung cancer physician-scientist. As leader of the Lung Cancer Program for the Dana-Farber/Harvard Cancer Center in Boston, he oversees research that integrates the facilities’ patient populations and science and applies what is discovered to the treatment of patients with lung cancer, malignant mesothelioma, and other thoracic malignancies. Under
Dr. Hassan A. Khalil is a thoracic surgeon at both Brigham and Women’s Hospital and Dana-Farber Cancer Institute. He specializes in minimally invasive surgical techniques in the treatment of thoracic and foregut diseases including malignant mesothelioma and lung cancer. He is a certified robotic console surgeon in the da Vinci Xi robotic platform and is also
Dr. David M. Jackman is a thoracic oncologist who is dedicated to improving outcomes for patients diagnosed with lung cancer, malignant pleural mesothelioma, and thymic tumors at the Dana-Farber Cancer Institute. As a physician member of the Lowe Center for Thoracic Oncology, he collaborates with experts across medical disciplines to coordinate and create a plan
Dr. Petr F. Hausner is a medical oncologist at the University of Maryland Health and is a member of the Greenebaum Comprehensive Cancer Center’s Mesothelioma and Thoracic Oncology Treatment and Research Center. His clinical specialties are hematology/oncology, thoracic oncology, gastrointestinal oncology, and cutaneous oncology. Working with a multidisciplinary team of surgeons, oncologists, and others, he
Dr. Katherine A. Scilla is a medical oncologist at the University of Maryland Medical Center and part of the Greenebaum Comprehensive Cancer Center’s Mesothelioma and Thoracic Oncology Treatment and Research Center Team. She specializes in treating chest and thoracic cancers, including malignant pleural mesothelioma, lung cancer, and thymic cancers. Dr. Scilla is part of a
Mesothelioma is a particularly challenging form of cancer that has proven extremely resistant to traditional treatment protocols. Most patients are offered multimodality treatments that include chemotherapy, and that regimen can lead to a troubling side effect referred to as ‘chemobrain.’ This week researchers have published a study that suggests that it may be caused by
Dr. Jordan D. Miller is a thoracic surgeon and member of the Lung and Thoracic Cancer Team at the University of Kentucky’s UK Markey Cancer Center. He specializes in treating patients with lung cancer, esophageal cancer, malignant pleural mesothelioma, and other conditions, using a variety of high-level techniques including minimally invasive surgery and video-assisted thoracoscopic
Dr. Chao H. Huang is a specialist in the field of clinical hematology and medical oncology at the Kansas University Medical Center and the University of Kansas Cancer Center. As director of the Lung Cancer Program, he leads a multidisciplinary team of radiation and medical oncologists, pathologists, pulmonary medicine specialists, and thoracic surgeons in diagnosing
Dr. Kalpaj R. Parekh is an experienced and accomplished cardiothoracic surgeon at the University of Iowa Hospitals and Clinics, as well as the Holden Comprehensive Cancer Center. While his primary interest is in lung transplantation, his clinical efforts and expertise include surgical care of lung cancer and esophageal cancer patients. His technical skills include lung transplant,